DRTS — Alpha Tau Medical Cashflow Statement
0.000.00%
Last trade - 00:00- $173.48m
- $97.30m
- 42
- 27
- 41
- 29
Annual cashflow statement for Alpha Tau Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.46 | -8.88 | -27.3 | -33.8 | -29.2 |
| Depreciation | |||||
| Non-Cash Items | 1.55 | 0.646 | 14.1 | 9.21 | 7.63 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.064 | 0.899 | 0.585 | -0.307 | 2.49 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -6.91 | -7.25 | -11.8 | -23.9 | -18 |
| Capital Expenditures | -1.29 | -3.77 | -2.93 | -0.904 | -6.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -8.87 | -4.05 | 22.2 | -89 | 25.1 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -10.2 | -7.82 | 19.3 | -89.9 | 18.7 |
| Financing Cash Flow Items | -0.946 | 0 | 0 | 93.5 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 5.32 | 29.3 | 0.111 | 96.9 | 5.3 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -11.8 | 14.3 | 7.68 | -17.2 | 5.97 |